207 related articles for article (PubMed ID: 14993455)
1. Ephedra: once a boon, now a bane.
Scheindlin S
Mol Interv; 2003 Oct; 3(7):358-60. PubMed ID: 14993455
[No Abstract] [Full Text] [Related]
2. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
[TBL] [Abstract][Full Text] [Related]
3. FDA v. ephedra: is it time to lift the ban?
Pyle KR
Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
[No Abstract] [Full Text] [Related]
4. Medicine. Ephedra--scientific evidence versus money/politics.
Wolfe SM
Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
[No Abstract] [Full Text] [Related]
5. Ephedra ban: no shortage of reasons.
Rados C
FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
[TBL] [Abstract][Full Text] [Related]
6. Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects.
Shekelle P; Hardy ML; Morton SC; Maglione M; Suttorp M; Roth E; Jungvig L; Mojica WA; Gagné J; Rhodes S; McKinnon E
Evid Rep Technol Assess (Summ); 2003 Mar; (76):1-4. PubMed ID: 12647510
[No Abstract] [Full Text] [Related]
7. Ephedrine alkaloids banned from dietary supplements.
Thompson CA
Am J Health Syst Pharm; 2004 Apr; 61(8):750-2, 756. PubMed ID: 15127956
[No Abstract] [Full Text] [Related]
8. The need for regulation of dietary supplements--lessons from ephedra.
Fontanarosa PB; Rennie D; DeAngelis CD
JAMA; 2003 Mar; 289(12):1568-70. PubMed ID: 12672775
[No Abstract] [Full Text] [Related]
9. The federal ban on ephedrine dietary supplements:an important event for pain practitioners and patients.
Lipman AG
J Pain Palliat Care Pharmacother; 2004; 18(3):1-4. PubMed ID: 15364627
[No Abstract] [Full Text] [Related]
10. "Tag--we're it".
Czap A
Altern Med Rev; 2003 May; 8(2):104. PubMed ID: 12777156
[No Abstract] [Full Text] [Related]
11. Ephedra: heart dangers in disguise.
Consum Rep; 2004 Jan; 69(1):22-3. PubMed ID: 14677546
[No Abstract] [Full Text] [Related]
12. HHS to study ephedra, step up enforcement against illegal marketing.
FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
[No Abstract] [Full Text] [Related]
13. Dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule.
Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services
J Pain Palliat Care Pharmacother; 2004; 18(3):95-107. PubMed ID: 15364637
[TBL] [Abstract][Full Text] [Related]
14. Working to get ephedra banned.
Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
[No Abstract] [Full Text] [Related]
15. JAMA patient page. Ephedra and ephedrine.
Torpy JM; Lynm C; Glass RM
JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
[No Abstract] [Full Text] [Related]
16. Banning ephedra: good call, poor vision.
Gordon JS
Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
[No Abstract] [Full Text] [Related]
17. Safety concerns prompt US ban on dietary supplement.
Knight J
Nature; 2004 Jan; 427(6970):90. PubMed ID: 14712244
[No Abstract] [Full Text] [Related]
18. FDA to ban sales of dietary supplements containing ephedra.
Ling AM
J Law Med Ethics; 2004; 32(1):184-6. PubMed ID: 15152444
[No Abstract] [Full Text] [Related]
19. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
Seamon MJ; Clauson KA
J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
[TBL] [Abstract][Full Text] [Related]
20. [Ephedrine and ephedra in weight loss products and other preparations].
van der Hooft CS; Stricker BH
Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]